Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Bonviva for Pain Relief After Vertebral Osteoporotic Fracture
NCT00493623Phase 3Completed
- Sponsor
- Roche
- Start
- Jun 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Vertebral fracture and osteoporosis comparing Bonviva with Placebo (2 arms). Primary endpoint: Success of Bonviva therapy (>=20% diminution of pain intensity) at Day 7. Started Jun 2007; status: completed.
02
Drugs
ibandronate
03
Conditions
Vertebral fractureosteoporosis
Beyond the preview
Go deeper on NCT00493623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00493623.